miR-195 reduces age-related blood-brain barrier leakage caused by thrombospondin-1-mediated selective autophagy

Chien-Yuan Chen1, Yung-Mei Chao2, Hsiu-Fen Lin3,4

  • 1Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.

Aging Cell
|October 8, 2020
PubMed

Insights

MicroRNA-195 (miR-195) protects the blood-brain barrier (BBB) by suppressing thrombospondin-1 (TSP1), which reduces the degradation of tight junction proteins. Restoring miR-195 levels may maintain BBB integrity and prevent neurodegeneration.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Cell Biology

Background:

  • Blood-brain barrier (BBB) disruption is implicated in neurodegenerative diseases.
  • Loss of tight junction (TJ) proteins in cerebral endothelial cells (ECs) compromises BBB integrity.
  • Previous findings suggest miR-195 offers vasoprotection.

Purpose of the Study:

  • To investigate the role of miR-195 in maintaining BBB integrity.
  • To elucidate the molecular mechanisms by which miR-195 influences BBB function.
  • To explore therapeutic potential for BBB repair.

Main Methods:

  • Analysis of cerebral miR-195 levels in aged and knockout mice.
  • Exosome-mediated delivery of miR-195 to cerebral ECs.
  • Investigation of TJ protein metabolism via the autophagic-lysosomal pathway.
  • Proteomic analysis to identify miR-195 targets.
  • TSP1 antibody administration and miR-195 delivery in vivo.
  • Correlation analysis of serum TSP1 levels in dementia patients.

Main Results:

  • Cerebral miR-195 levels decrease with age, correlating with increased BBB leakage.
  • miR-195 knockout mice exhibit significantly increased BBB leakage.
  • Exosomes containing miR-195 enhance TJ proteins and BBB integrity.
  • TSP1 promotes TJ protein degradation by activating selective autophagy.
  • TSP1 levels are elevated in dementia patients with BBB damage.
  • TSP1 antibody treatment and miR-195 delivery reduce BBB leakage.

Conclusions:

  • miR-195 preserves BBB integrity by suppressing TSP1-mediated selective autophagy of TJ proteins.
  • TSP1 acts as a key mediator of BBB disruption through enhanced TJ protein degradation.
  • Targeting the miR-195/TSP1 axis offers a potential therapeutic strategy for BBB repair in neurodegenerative diseases.